114 related articles for article (PubMed ID: 5931752)
1. Radiation-induced changes in the properdin system of the dog and a critical analysis of the general problem.
Michaelson SM; Shively JN; Haydock IC
Radiat Res; 1966 May; 28(1):60-70. PubMed ID: 5931752
[No Abstract] [Full Text] [Related]
2. [Microchemical method for the determination of properdin].
Pfordte K
Z Gesamte Exp Med Einschl Exp Chir; 1966; 140(4):294-302. PubMed ID: 5991291
[No Abstract] [Full Text] [Related]
3. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
[No Abstract] [Full Text] [Related]
4. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
[No Abstract] [Full Text] [Related]
5. [Properdin research. 1. Review of the properdin system and its problems; determination possibilities, assay of sera with high titer levels].
Zimmermann G
Arch Exp Veterinarmed; 1972; 26(2):221-46. PubMed ID: 4562974
[No Abstract] [Full Text] [Related]
6. [ULTRACENTRIFUGE STUDIES ON PROPERDIN SERA OF ZYMOSAN-VACCINATED CATTLE, RABBITS, GUINEA PIGS, RATS AND MICE AND ON BOVINE PROPERDIN SERUM FRACTIONS].
ZIMMERMANN G; KRUEGER K
Acta Biol Med Ger; 1963; 11():902-17. PubMed ID: 14121884
[No Abstract] [Full Text] [Related]
7. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
[TBL] [Abstract][Full Text] [Related]
8. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
Brade V; Nicholson A; Bitter-Suermann D; Hadding U
J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
[No Abstract] [Full Text] [Related]
9. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
Brade V; Nicholson A; Lee GD; Mayer MM
J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
[No Abstract] [Full Text] [Related]
10. Some observations on the properdin system. 8. Properdin and its relation to blood constituents of human and some laboratory animals.
Majumdar AC; Datta TK; Sarma AK; Ray MK
J Indian Med Assoc; 1972 Nov; 59(10):428-31. PubMed ID: 4658784
[No Abstract] [Full Text] [Related]
11. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
HOOK WA; CAREY WF; MUSCHEL LH
J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
[No Abstract] [Full Text] [Related]
12. SOME RES EFFECTS INFLUENCING RADIATION SURVIVAL TIME.
SZANTO A
Acta Unio Int Contra Cancrum; 1964; 20():1233-5. PubMed ID: 14274743
[No Abstract] [Full Text] [Related]
13. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
14. [Effect of non-specific stimulation with zymosan on serum properdin level in patients with neoplasms].
Dobrek Z; Majewski S; Maciejewski B
Pol Tyg Lek; 1972 Jul; 27(24):905-8. PubMed ID: 5040537
[No Abstract] [Full Text] [Related]
15. [PROPERDIN AND ANAPHYLATOXIN].
WILLEMS G
Rev Immunol Ther Antimicrob; 1963; 27():285-90. PubMed ID: 14111198
[No Abstract] [Full Text] [Related]
16. EFFECT OF ULTRAVIOLET IRRADIATION ON THE PROPERDIN LEVEL OF PIGS' SERA IN VITRO.
SZEMERE G
Med Pharmacol Exp Int J Exp Med; 1965; 12():366-72. PubMed ID: 14332240
[No Abstract] [Full Text] [Related]
17. [Methodological bases for animal experiments with the use of ionizing radiation].
Gajewski AK; Rózycki Z
Rocz Panstw Zakl Hig; 1974; 25(5):583-95. PubMed ID: 4420848
[No Abstract] [Full Text] [Related]
18. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
Ferrauto A; Giuffrida G; Terranova R
Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1488-91. PubMed ID: 5878160
[No Abstract] [Full Text] [Related]
19. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
FUMAROLA D; MODICA F
Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
[No Abstract] [Full Text] [Related]
20. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
